Loading...
US incentive scheme for neglected diseases: a good idea gone wrong?
Doshi, Peter
Doshi, Peter
Advisor
Date
2014-07-21
Embargo until
Language
Book title
Journal
Publisher
BMJ Publishing Group
Peer Reviewed
Type
Article
Research Area
Jurisdiction
Collections
Files
Other Titles
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
The US priority review voucher scheme was intended to encourage drug companies to invest in treatments for neglected diseases. But nearly seven years on, the author reports, there is little demonstrated innovation and evidence that the benefits are not going where they were intended.
Series/Report No.
Sponsors
Rights/Terms
Citation
Doshi, P. (2014). US incentive scheme for neglected diseases: a good idea gone wrong? BMJ, 349. DOI: 10.1136/bmj.g4665